Pictet Asset Management Sa Neurocrine Biosciences Inc Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pictet Asset Management Sa holds 924,416 shares of NBIX stock, worth $129 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
924,416
Previous 724,244
27.64%
Holding current value
$129 Million
Previous $73.3 Million
18.91%
% of portfolio
0.1%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
626Shares Held
94MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.98 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.39 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$718 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$359 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$260 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...